LATEST PRESS RELEASES


Notice: Function WP_Object_Cache::add was called incorrectly. Cache key must not be an empty string. Please see Debugging in WordPress for more information. (This message was added in version 6.1.0.) in /var/www/vhosts/shroominvestor.com/httpdocs/web/wp/wp-includes/functions.php on line 6031

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Plans on Emergency Use Access

TORONTO, Dec. 23, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinica... Read More...

Red Light Holland Looking To Receive Exemption for Controlled Substances from Government of Canada, Engages Wellington Dupont Public Affairs

Toronto, Ontario--(Newsfile Corp. - December 23, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) ("Red Light Holland" or the "Company") is pleased to announce that it has hired Wellington-Dupont Public Affairs ("Wellington-Dupont") to provide government relations support and lobbying services on behalf of the Company. ... Read More...

Early Warning Report for Eastwood Capital Corp.

VANCOUVER, BC, Nov. 2, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that, further to its news release dated October 9, 2020, it has entered into a definitive amalgamation agreement, (the "Definitive Agreement") with Pilz Bioscience Corp. ("Pilz") and 1271642 B.C. Ltd. ("Nova ... Read More...

Mountain Valley MD Holdings Oversubscribes Strategic Private Placement Offering of Units

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be... Read More...

Havn Life Sciences and Nesters Market, a Leading Canadian Retailer of Natural Health and Wellness Products, Announce an Authorized Products Listing

Nesters Market retail chain, will list and promote the full range of Havn Life's natural health supplements across its stores in British Columbia in Q1 2021VANCOUVER, BC / ACCESSWIRE / December 22, 2020 / Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of... Read More...

Hollister Biosciences Inc.’s Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery Launches 2nd Depot in Sacramento, California

VANCOUVER, BC, Dec. 22, 2020 - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 80 dispensaries throughout Arizona, is pleased to announce the launch of... Read More...

New Wave Enters into Definitive Agreement to Acquire Way of Will Inc. – A Leading Retailer of Aromatherpy Products Extracted from Natural Aromatic Plant Extracts and Essential Oils

/NOT FOR DISTRIBUTION IN THE U.S. OR OVER U.S. NEWSWIRES./TORONTO, Dec. 21, 2020 - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTC: TRMNF) an investment issuer that provides capital and support services, is pleased to announced that further to its press release dated December 15, 2020, it has entered int... Read More...

PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics

PharmaTher to focus on FDA human clinical trials of ketamine for Parkinson’s disease, depression and painTORONTO, Dec. 21, 2020 -- PharmaTher Inc., (“PharmaTher” or the “Company”), a wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM) (OTC Pink: PHRRF) and a specialty life sciences company focused on the research and devel... Read More...

Revive Therapeutics Announces LOI to Acquire PharmaTher’s Psilocybin Program

TORONTO, Dec. 21, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”), dated December 20... Read More...

Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials

DENVER, Dec. 21, 2020 -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced that it has engaged ethica CRO ("ethica CRO"), a full-servic... Read More...

BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC

VANCOUVER, Dec. 20, 2020 -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) is pleased to announce that further to its press release of December 8, 2020, the Company has completed its acquisition to acquire 100% of the assets in Transcend Biodynamics LLC (“Transcend”) in an all-stock transacti... Read More...

Havn Life Sciences Files Preliminary Prospectus in Connection with Bought Deal Equity Financing

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / December 18, 2020 / Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn Life") is pleased to announce, further to its previously announced offering (the "Offering") on December 15, 2020, that it has filed a pre... Read More...

Entheon Biomedical Announces Private Placement

Vancouver, British Columbia--(Newsfile Corp. - December 18, 2020) -  Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company") announces that it is proceeding with a fully allocated, non-brokered private placement financing of 4,266,997 Units (the "Units") at a price of CDN$0.75 per Unit for gross proceeds of CDN$3,200... Read More...

Bruce Linton Announces Filing of Early Warning Report Regarding Vireo Health International, Inc.

TORONTO, Dec. 17, 2020 - Bruce Linton today announced that he has filed an early warning report under National Instrument 62-103 in connection with the disposition of an aggregate of 1,114,115 subordinate voting shares (the "Shares") of Vireo Health International, Inc. (the "Corporation").On December 17, 2020, the Linton Family Trust (204... Read More...

Empower Clinics Signs Definitive Agreement to Acquire Momentum Health With 7 Canadian Clinics. Begins Planning for Nationwide Rollout

Acquisition Will Expand Company's North American Footprint And Strengthen Vertical Integration From Patients To Laboratory, Strengthening Testing and Bubble InitiativesVANCOUVER, BC / ACCESSWIRE / December 17, 2020 / Empower Clinics (CSE:CBDT)(OTC PINK:EPWCF)(FRA:8EC) (the "Company" or "Empower"), an integrated healthcare company serving ... Read More...

Plant & Co. Brands Collaborates with the University of Manitoba to Develop an All-Natural Hemp-Based Food Line

Toronto, Ontario--(Newsfile Corp. - December 17, 2020) -  Plant & Co. Ltd. (CSE: VEGN) (FSE: VGP) (OTC PINK: EURPF) ("Plant & Co." or the "Company"), a vertically integrated enterprise focused on the health and wellness sector, is pleased to announce that it has signed an agreement with the University of Manitoba to develop a prop... Read More...

Psychedelic Wellness-Focused Company Delic Corp. Announces Record Monthly Traffic on Reality Sandwich and Launch of E-Commerce Store

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN UNITED STATES/VANCOUVER, BC, Dec. 16, 2020 - Delic Corp. ("DELIC" or the "Company") (CSE: DELC), a psychedelic wellness-focused company, is pleased to announce that Reality Sandwich (realitysandwich.com), a subsidiary of DELIC, had its highest record of traff... Read More...

Havn Life Sciences Hits Major Milestone with Research Partner, Complex Biotech Discovery Ventures

Havn Research signs contract with CBDV, located at The University of British Columbia's Vancouver campus, to begin Health Canada approved research to analyze psilocybin under Havn Life's Section 56 exemption.The results of the analysis will allow Havn Life to begin the development of a library of psilocybin compounds.VANCOUVER, BC / ACCES... Read More...

Pure Extracts Commences Build-Out of Facility in Preparation for Mushroom Extraction and Dealer’s Licence

VANCOUVER, British Columbia, Dec. 16, 2020 -- Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company, is pleased to announce that it has begun to build-out the 4th unit in its facility for the extraction of mushrooms and to commence research and development of psilo... Read More...

Canada and Ontario invest in green infrastructure to support residents of Pays Plat First Nation and Biigtigong Nishnaabeg First Nation

VANCOUVER, BC, Dec. 3, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that it has appointed Dr. Marvin S. Hausman, MD as Chairman of its Scientific Advisory Board, effective immediately. Dr. Hausman is the Chief Medical Officer of Pilz Bioscience Corp., a wholly-owned subsidiar... Read More...

New Wave Enters Into Letter of Intent to Acquire Way of Will Inc. – A Leading Retailer of Aromatherpy Products Extracted From Natural Aromatic Plant Extracts and Essential Oils

/NOT FOR DISTRIBUTION IN THE U.S. OR OVER U.S. NEWSWIRES/NEW WAVE ENTERS INTO LETTER OF INTENT TO ACQUIRE WAY OF WILL INC.– A LEADING RETAILER OF AROMATHERPY PRODUCTS EXTRACTED FROM NATURAL AROMATIC PLANT EXTRACTS AND ESSENTIAL OILS (CNW Group/New Wave Holdings Corp.)TORONTO, Dec. 15, 2020 - NEW WAVE HOLDINGS CORP. (the "Company" or "New ... Read More...

CREA Updates Resale Housing Market Forecast

In excess of $5 Million cash on hand to evaluate new product candidates including psychedelic product research opportunities and support existing product line launchVANCOUVER, BC, Nov. 19, 2020 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("Mind Cure" or the "Company") is pleased to announce that is has closed, on an over... Read More...

Silo Pharma, Inc. Enhances Scientific Advisory Board with Appointment of Dr. Charles B. Nemeroff of University of Texas at Austin

Englewood Cliffs, NJ, Dec. 15, 2020 -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that its Board of Directors has named clinical researcher and professor, Dr. Charles B. Nemeroff, M.D., Ph.D., to its Scientific Advisory Board.Dr. Nemero... Read More...

Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming Français

The combination further enhances Numinus' leadership position in evidence-based psychedelic-assisted psychotherapy and health solutions VANCOUVER, BC, Dec. 15, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, acces... Read More...

Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming

The combination further enhances Numinus' leadership position in evidence-based psychedelic-assisted psychotherapy and health solutions VANCOUVER, BC, Dec. 15, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, acces... Read More...

Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

Leading FDA consultancy firm to advise on drug development and clinical trial pipelineDENVER, Dec. 15, 2020 -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic m... Read More...

Hollister Biosciences Inc. Signs Exclusive Agreement with Easyriders to Design, Manufacture and Produce a National Cannabis Product Line

Landmark Deal Establishes Iconic Pairing of Cannabis and Motorcycle CulturesVANCOUVER, Dec. 15, 2020 - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") has its roots in the birthplace of the American biker, and Easyriders has been the definitive voice of motorcyc... Read More...

BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application

VANCOUVER, Dec. 14, 2020 -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of cutting edge treatments, today announced the value proposition of its acquisition of Transcend Biodynamics, LLC’s (“Transcend”) manufacturing pat... Read More...